Astec LifeSciences Limited (ASTEC) fundamentals
Astec LifeSciences Limited is a listed company in Fertilizers & Agrochemicals, part of the Chemicals sector, listed on the NSE as ASTEC (ISIN INE563J01010). This page carries its reported financials, balance sheet, cash flow, shareholding pattern and valuation ratios.
What Astec LifeSciences Limited does
Astec LifeSciences Limited is an India-based company, which is engaged in the manufacturing of agrochemical active ingredients (technical), bulk, formulations and intermediate products. The Company undertakes contract development and manufacturing services for a diverse range of agrochemicals. The Company operates through a single segment, namely Agrochemicals. Its product categories include Fungicide, Growth Regulator, Intermediates, Insecticide, and Herbicide. Its products include Azimsulfuron, Halosulfuron, Flutriafol, Rimsulfuron, Transfluthrin, Prothiaconazole, Metalaxyl, Cyproconazole, and Tribenuron methyl. It has a sales mix of both exports and domestic sales. It exports to approximately 17 countries, including the United States and countries across Europe, West Asia, South-East Asia, Latin America and Africa. The Company has approximately nine manufacturing plants, which are located in Maharashtra.
Valuation and market data
| Last close | ₹715.80 |
|---|---|
| Market capitalisation | ₹1,532 crore |
| Enterprise value | ₹1,573 crore |
| P/E (TTM) | 0.00 |
| Price to book | 3.92 |
| Price to sales (TTM) | 2.09 |
| Book value per share | ₹182.66 |
| Dividend yield | 0.00% |
| Sector | Chemicals |
| Industry | Fertilizers & Agrochemicals |
| Listed since | Wed Nov 25 |
Annual results
| Period | Revenue | Profit before tax | Net profit | EPS |
|---|---|---|---|---|
| Mar 2026 | ₹453 crore | ₹-81 crore | ₹-81 crore | -37.79 |
| Mar 2025 | ₹387 crore | ₹-141 crore | ₹-135 crore | -68.71 |
| Mar 2024 | ₹464 crore | ₹-62 crore | ₹-47 crore | -23.93 |
| Mar 2023 | ₹641 crore | ₹35 crore | ₹26 crore | 13.04 |
Figures are as reported (consolidated), in ₹ crore.
Shareholding pattern
As of Jun 2026:
| Promoters | 72.0% |
|---|---|
| Foreign institutions (FII) | 0.0% |
| Mutual funds | 3.0% |
| Other domestic institutions | 0.3% |
| Retail and others | 24.7% |
More on BreakPoint
FundaX company research covers every listed company with reported financials. BreakPoint Pro adds the BreakPoint iQ score, the screener and the multibagger board.
Data is sourced from exchange filings and vendor feeds and is for research, not investment advice. Figures can be restated by the company after publication.